TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Canadian Pot Legalization Could Be A Fresh Tailwind for Cannabis Stocks
Play
INVESTING

Pot Stocks Stay Volatile - Here’s What’s Happening Friday

  • By M. Corey Goldman
  • 16 minutes ago
Trulieve Cannabis Lead
INVESTING

How to Trade Tilray and Aphria as Volatility Ramps Up

  • By Bret Kenwell
  • 20 hours ago
Pot Stock Tilray Just Had One of the Most Mind-Blowing Sessions Ever
INVESTING

Tilray, Aurora, Cannabis Stocks Surging on Deals and Reddit Boost

  • By Rob Lenihan
  • Feb 10, 2021 11:27 AM EST
We Met the Most Popular Guy at a Big Cannabis Conference in NY
INVESTING

OrganiGram Spikes as Cannabis Stocks Continue Their Rally

  • By Rob Lenihan
  • Feb 8, 2021 2:13 PM EST
Jim Cramer's Reaction to Canopy Growth's Partnership with Martha Stewart
INVESTING

Here's What Canopy Growth Bulls Want to See After Earnings

  • By Bret Kenwell
  • Feb 8, 2021 11:59 AM EST
DraftKings Lead
INVESTING

Best Stocks in the Past Week: Virgin Galactic, Zillow, Penn National

  • By Danny Peterson
  • Feb 8, 2021 8:49 AM EST
Juva Cannabis Lead
CANNABIS

Cannabis Stocks Watchlist: Tilray, Village Farms, Canopy Growth

  • By Danny Peterson
  • Feb 10, 2021 8:44 AM EST
PRESS RELEASES

Lifshitz Law Firm, P.C. Announces Investigation Of CNIG, GWPH, JAZZ, HOL, JWS, KTYB, SYBT, PRSP, PROS, And VIE

  • By PR Newswire
  • Feb 7, 2021 12:00 PM EST
PRESS RELEASES

SHAREHOLDER ALERT: WeissLaw LLP Investigates GW Pharmaceuticals Plc

  • By PR Newswire
  • Feb 3, 2021 4:46 PM EST
What to Watch Out for in Kohl's Earnings
INVESTING

Kohl's, Sony, Overstock: 5 Top Stock Gainers for Wednesday

  • By Rob Lenihan
  • Feb 3, 2021 4:24 PM EST
GW Pharma (GWPH) Stock Spiked on Promising Cannabis-Derived Drug, Jim Cramer's Take
INVESTING

Aphria, Cannabis Stocks Soar as Jazz Pharma to Buy GW Pharma

  • By Dan Weil
  • Feb 7, 2021 10:13 AM EST
Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers
INVESTING

How to Trade Jazz Pharmaceuticals After Its Acquisition of GW Pharma

  • By Bret Kenwell
  • Feb 3, 2021 2:29 PM EST
UPS Suspends Deliveries to Qatar From Neighbors as Gulf Tensions Rise
INVESTING

Morning Bell With Jim Cramer: Buy UPS and Ford

  • By Vidhi Choudhary
  • Feb 3, 2021 8:51 AM EST
Medicines Co. Jumps on Pair of Bullish Notes
INVESTING

GW Pharma Will Be Acquired by Jazz Pharmaceuticals

  • By M. Corey Goldman
  • Feb 3, 2021 10:20 AM EST
PRESS RELEASES

Jazz Pharmaceuticals Announces Initiation Of Biologics License Application Submission For JZP-458 For The Treatment Of Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma

  • By PR Newswire
  • Dec 21, 2020 8:00 AM EST
PRESS RELEASES

Jazz Pharmaceuticals And PharmaMar Announce Results Of ATLANTIS Phase 3 Study Evaluating Zepzelca™ In Combination With Doxorubicin For Patients With Small Cell Lung Cancer Following One Prior Platinum-containing Line

  • By PR Newswire
  • Dec 3, 2020 2:00 AM EST
PRESS RELEASES

Jazz Pharmaceuticals Appoints Jennifer Cook And Mark Smith, M.D. To Its Board Of Directors

  • By PR Newswire
  • Nov 17, 2020 7:30 AM EST
Jazz Pharmaceuticals Lead
INVESTING

Jazz Pharmaceuticals Up on Third Quarter Earnings Beat

  • By Rob Lenihan
  • Nov 3, 2020 1:26 PM EST
PRESS RELEASES

Jazz Pharmaceuticals Announces New Sleep Health Collaboration

  • By PR Newswire
  • Sep 15, 2020 8:00 AM EDT
PRESS RELEASES

Acerus Announces Addition Of US Commercial Leader

  • By Business Wire
  • Sep 14, 2020 7:30 AM EDT
PRESS RELEASES

National Comprehensive Cancer Network® Adds Zepzelca™ (lurbinectedin) To Clinical Practice Guidelines In Oncology

  • By PR Newswire
  • Jul 13, 2020 8:00 AM EDT
PRESS RELEASES

Jazz Pharmaceuticals Announces U.S. FDA Accelerated Approval Of Zepzelca™ (lurbinectedin) For The Treatment Of Metastatic Small Cell Lung Cancer

  • By PR Newswire
  • Jun 15, 2020 3:35 PM EDT
PRESS RELEASES

Jazz Pharmaceuticals Announces Appointment Of Kim Sablich As Executive Vice President, General Manager Of North America

  • By PR Newswire
  • May 11, 2020 8:30 AM EDT
PRESS RELEASES

Bionical Emas And Jazz Pharmaceuticals Enter Into An Agreement For Expanded Access To Lurbinectedin In Relapsed Small Cell Lung Cancer In The United States

  • By PR Newswire
  • May 11, 2020 8:30 AM EDT
PRESS RELEASES

Jazz Pharmaceuticals Stops Enrollment In Phase 3 Study Evaluating Defibrotide For The Prevention Of Veno-Occlusive Disease

  • By PR Newswire
  • Apr 29, 2020 4:05 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.